Literature DB >> 9552026

Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse.

C V Fernandez1, C A Stutzer, L MacWilliam, C Fryer.   

Abstract

PURPOSE: Alternative and complementary therapies are infrequently studied in pediatric populations. We performed a population-based survey to aid health care workers in identifying and counseling parents who may use these remedies. PATIENTS AND METHODS: We retrospectively surveyed the parents of 583 pediatric patients diagnosed with cancer in British Columbia between 1989 and 1995. Prevalence and factors that influence the use and nonuse of alternative and complementary therapies were estimated.
RESULTS: Alternative and complementary therapies were used by 42% of 366 respondents. Herbal teas, plant extracts, and therapeutic vitamins were the most commonly used alternative therapies. Relaxation/imagery strategies, massage, and therapeutic touch were the most commonly used complementary techniques. Factors that influenced the use of alternative/complementary therapies were prior use (chi2 = 60.0, P < .0001), prior positive attitude towards these remedies (chi2 = 41.6, P < .0001), soliciting information from family and friends (chi2 = 70.5, P < .0001) or from alternative care givers (chi2 = 58.7, P < .0001), high risk of death at diagnosis (chi2 = 9.6, P < .002), and advanced education of the father (chi2 = 7.4, P < .006) or mother (chi2 = 8.6, P < .003). Parents who used alternative/complementary therapies did so in conjunction with conventional medicine (98%). Lack of knowledge and fear of interference with conventional therapies were the most common reasons cited for nonuse. No parent believed that the quality of life of their child deteriorated due to the use of alternative/complementary therapies.
CONCLUSION: Alternative and complementary therapy use in pediatric oncology patients is common. Factors have been identified that may be associated with undertaking their use.

Entities:  

Mesh:

Year:  1998        PMID: 9552026     DOI: 10.1200/JCO.1998.16.4.1279

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  32 in total

1.  Why are children with cancer being exposed to complementary medicine?

Authors:  S F Whitsett; R Anderson; M J Coppes
Journal:  West J Med       Date:  1999-09

2.  Is it time for oncologists to modify their laissez-faire attitude toward alternative/complementary 'drug therapy'?

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

3.  Chiropractic care for children: Controversies and issues.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-02       Impact factor: 2.253

4.  [Not Available].

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

5.  The CAM network - Challenges and opportunities.

Authors:  Michael J Rieder
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

6.  Children and natural health products: What a clinician should know.

Authors: 
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

7.  Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.

Authors:  Anthony P Wong; Ann L Clark; Elizabeth A Garnett; Michael Acree; Stanley A Cohen; George D Ferry; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-01       Impact factor: 2.839

8.  Use of homeopathy in pediatric oncology in Germany.

Authors:  Alfred Längler; Claudia Spix; Friedrich Edelhäuser; Genn Kameda; Peter Kaatsch; Georg Seifert
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-22       Impact factor: 2.629

9.  Is there a role for complementary therapy in the management of leukemia?

Authors:  Kathleen M Wesa; Barrie R Cassileth
Journal:  Expert Rev Anticancer Ther       Date:  2009-09       Impact factor: 4.512

10.  Issues in the management of dietary supplement use among hospitalized patients.

Authors:  Edward Boyer
Journal:  J Med Toxicol       Date:  2005-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.